台湾の薬学生のキャリア適応能力: 定性的な研究
Shih-Ming Chen1, Ming-Chia Lee2, Tsz-Yi Chang3
1School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Currents in pharmacy teaching & learning
|February 21, 2026
まとめ
複雑な役割を担う薬剤師の学生にとって,キャリアの適応性は極めて重要です. 高い適応能力は,積極的な計画と探求を伴うが,低い適応能力は,自信と好奇心を育てるための教育支援を必要とする.
科学分野:
- 薬局 教育 教育 薬局教育
- キャリア開発 キャリア開発
- 心理社会的リソース
背景:
- 薬局の役割はますます複雑で不確実になり,キャリアの適応性を必要としています.
- Savickasの4次元フレームワークで定義されたキャリアの適応性は,キャリアのタスクと移行を管理するために不可欠です.
- 薬学教育におけるキャリア適応性に関する証拠は限られている.
研究 の 目的:
- 台湾の3年生薬学生のキャリア適応性を調査する.
- 適応力に対する関心,コントロール,好奇心,自信の影響を調べる.
- 薬学生の適応能力の高低を区別する要因を特定する.
主な方法:
- 台湾の3年生薬学生12人を対象とした定性研究.
- 高いまたは低い適応性に基づく意図的なサンプリング.
- 半構造面接と適応能力の側面のテーマ分析.
主要な成果:
- 適応能力の高い学生は,積極的な関心,より強い自己規制,より広範な好奇心,より高い自信を示しました.
- 適応能力の低い生徒は,計画が遅れていること,試験への集中が狭いこと,探索が限られていること,自信が持てないことを示した.
- 好奇心は,不安と自信とともに,重要な差異化要因として特定されました.
結論:
- 好奇心も,関心と自信と同じくらい,キャリアの適応力を形作るのに不可欠です.
- 反射的な学習,メンターシップ,多様なキャリアへの曝露などの教育戦略は,適応力を高めることができます.
- 適応力資源の強化は,薬局の卒業生を変化する医療環境に備えるために不可欠です.
さらに関連する動画
関連する概念動画
Bioavailability Study Design: Single Versus Multiple Dose Studies
274
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
274
Bioavailability Study Design: Healthy Subjects Versus Patients
172
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
172
Measurement of Bioavailability: Pharmacodynamic Methods
894
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
894
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
198
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
198
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
242
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
242
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
199
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
199


